Not only accumulation, but also saturation status of intramuscular lipids is significantly affected by PPARγ activation

Acta Physiologica

Volumn 205, Issue 1, 2012, Pages 145-158

  Chabowski, A ^a   Zendzian Piotrowska, M ^a   Nawrocki, A ^a   Gorski J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Lipids; Monounsaturated fatty acids; Peroxisome proliferator activated receptors; Polyunsaturated fatty acids; Rosiglitazone; Skeletal muscle

Indexed keywords

DIACYLGLYCEROL; FATTY ACID; FATTY ACID TRANSPORTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDURANCE TRAINING; FATTY ACID ANALYSIS; GAS LIQUID CHROMATOGRAPHY; GASTROCNEMIUS MUSCLE; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID DIET; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE; WESTERN BLOTTING;

ANIMALS; DIET, HIGH-FAT; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPIDS; MALE; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PPAR GAMMA; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 84859159730     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02380.x     Document Type: Article

References (58)

1. Andersson, A., Sjödin, A., Olsson, R. & Vessby, B. 1998. Effects of physical exercise on phospholipid fatty acid composition in skeletal muscle. Am J Physiol274(3 Pt 1), E432-E438.
2. Asplin, I., Galasko, G. & Larner, J. 1993. Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci USA90, 5924-5928.
3. Ayre, K.J. & Hulbert, A.J. 1996. Effects of changes in dietary fatty acids on isolated skeletal muscle functions in rats. J Appl Physiol80, 464-471.
4. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J. & Olefsky, J.M. 2006. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes55, 2277-2285.
5. Baur, L.A., O'Connor, J., Pan, D.A., Kriketos, A.D. & Storlien, L.H. 1998. The fatty acid composition of skeletal muscle membrane phospholipid: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism47, 106-112.
6. Bergman, B.C., Perreault, L., Hunerdosse, D.M., Koehler, M.C., Samek, A.M. & Eckel, R.H. 2010. Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes. J Appl Physiol108, 1134-1141.
7. Blachnio-Zabielska, A., Baranowski, M., Zabielski, P. & Gorski, J. 2010. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol225, 786-791.
8. Bonen, A., Luiken, J.J., Liu, S., Dyck, D.J., Kiens, B., Kristiansen, S., Turcotte, L.P., Van Vusse Der, G.J. & Glatz, J.F. 1998. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol275, E471-E478.
9. Bonen, A., Miskovic, D. & Kiens, B. 1999. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can J Appl Physiol24, 515-523.
10. Bonen, A., Chabowski, A., Luiken, J.J. & Glatz, J.F. 2007. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda)22, 15-29.
11. Bruce, C.R., Thrush, A.B., Mertz, V.A., Bezaire, V., Chabowski, A., Heigenhauser, G.J. & Dyck, D.J. 2006. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab291, E99-E107.
12. Cameron-Smith, D., Burke, L.M., Angus, D.J., Tunstall, R.J., Cox, G.R., Bonen, A., Hawley, J.A. & Hargreaves, M.A. 2003. Short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr77, 313-318.
13. Chabowski, A., Chatham, J.C., Tandon, N.N., Calles-Escandon, J., Glatz, J., Luiken, J.J. & Bonen, A. 2006. Fatty Acid Transport and FAT/CD36 are increased in red but not in white skeletal muscle of Zucker Diabetic Fatty (ZDF) Rats. Am J Physiol Endocrinol Metab291, E675-E682.
14. 2 myotubes. Arch Biochem Biophys419, 101-109.
15. Coburn, C.T., Knapp, F.F.Jr, Febbraio, M., Beets, A.L., Silverstein, R.L. & Abumrad, N.A. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem275, 32523-32529.
16. Czarkowska-Paczek, B., Zendzian-Piotrowska, M., Bartlomiejczyk, I., Przybylski, J. & Gorski, J. 2010. Skeletal and heart muscle expression of PDGF-AA and VEGF-A after an acute bout of exercise and endurance training in rats. Med Sci Monit.16, BR147-153.
17. Dobrzyn, P., Jazurek, M. & Dobrzyn, A. 2010a. Stearoyl-CoA desaturase and insulin signaling - what is the molecular switch?Biochim Biophys Acta1797, 1189-1194.
18. Dobrzyn, P., Pyrkowska, A., Jazurek, M., Szymanski, K., Langfort, J. & Dobrzyn, A. 2010b. Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1. J Appl Physiol109, 1653-1661.
19. Dyck, D.J., Peters, S.J., Glatz, J., Gorski, J., Keizer, H., Kiens, B., Liu, S., Richter, E.A., Spriet, L.L., van der Vusse, G.J. & Bonen, A. 1997. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol272, E340-E351.
20. Dyck, D.J., Miskovic, D., Code, L., Luiken, J.J. & Bonen, A. 2000. Endurance training increases FFA oxidation and reduces triacylglycerol utilization in contracting rat soleus. Am J Physiol Endocrinol Metab278, E778-E785.
21. Dyck, D.J., Steinberg, G. & Bonen, A. 2001. Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab281, E600-E607.
22. Ellis, B.A., Poynten, A., Lowy, A.J., Furler, S.M., Chisholm, D.J., Kraegen, E.W. & Cooney, G.J. 2000. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab279, E554-E560.
23. Gorski, J., Nawrocki, A. & Murthy, M. 1998. Characterization of free and glyceride- esterified long chain fatty acids in different skeletal muscle types of the rat. Mol Cell Biochem178, 113-118.
24. Han, X.X., Chabowski, A., Tandon, N.N., Calles-Escandon, J., Glatz, J.F., Luiken, J.J. & Bonen, A. 2007. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab293, E566-E575.
25. Harasim, E., Chabowski, A. & Górski, J. 2010. Lack of downstream insulin-mimetic effects of visfatin/eNAMPT on glucose and fatty acid metabolism in skeletal muscles. Acta Physiol (Oxf)202, 21-28.
26. He, J., Watkins, S. & Kelley, D. 2001. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes50, 817-823.
27. Helge, J.W. & Dela, F. 2003. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity?Diabetes52, 1881-1887.
28. Hockings, P.D., Changani, K.K., Saeed, N., Reid, D.G., Birmingham, J., O'Brien, P., Osborne, J., Toseland, C.N. & Buckingham, R.E. 2003. Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obes Metab5, 234-243.
29. Houmard, J.A., Tanner, C.J., Yu, C., Cunningham, P.G., Pories, W.J., MacDonald, K.G. & Shulman, G.I. 2002. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes51, 2959-2963.
30. Hulver, M.W., Berggren, J.R., Carper, M.J., Miyazaki, M., Ntambi, J.M., Hoffman, E.P., Thyfault, J.P., Stevens, R., Dohm, G.L., Houmard, J.A. & Muoio, D.M. 2005. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab2, 251-261.
31. Itoh, S., Shinomiya, K., Samejima, H., Ohta, T., Ishizuki, M. & Ichinose, S. 1996. Experimental study on nerve regeneration through the basement membrane tubes of the nerve, muscle, and artery. Microsurgery17, 525-534.
32. Janovská, A., Hatzinikolas, G., Mano, M. & Wittert, G.A. 2010. The effect of dietary fat content on phospholipid fatty acid profile is muscle fiber type dependent. Am J Physiol Endocrinol Metab298, E779-E786.
33. Jucker, B.M., Schaeffer, T.R., Haimbach, R.E., Mayer, M.E., Ohlstein, D.H., Smith, S.A., Cobitz, A.R. & Sarkar, S.K. 2003. Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study. Metabolism52, 218-225.
34. Kiens, B., Kristiansen, S. & Jensen, P. 1997. Membrane associated fatty acid binding protein (FABPpm) in human skeletal muscle is increased by endurance training. Biochem Biophys Res Commun231, 463-465.
35. Kiens, B., Roepstorff, C. & Glatz, J.F. 2004. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol97, 1209-1218.
36. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K. & Evans, R.M. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA91, 7355-7359.
37. Lee, J.S., Pinnamaneni, S.K., Eo, S.J., Cho, I.H., Pyo, J.H., Kim, C.K., Sinclair, A.J., Febbraio, M.A. & Watt, M.J. 2006. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol100, 1467-1474.
38. Lehmann, M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. & Kliewer, S.A. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem270, 12953-12956.
39. Lessard, S.J., Lo Giudice, S.L., Lau, W., Reid, J.J., Turner, N., Febbraio, M.A., Hawley, J.A. & Watt, M.J 2004. Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology145, 5665-5670.
40. Lessard, S.J., Rivas, D.A., Chen, Z.P., Bonen, A., Febbraio, M.A., Reeder, D.W., Kemp, B.E., Yaspelkis, B.B.3rd & Hawley, J.A. 2007. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes56, 1856-1864.
41. Listenberger, L.L., Han, X., Lewis, S.E., Cases, S., Farese, R.V.Jr, Ory, D.S. & Schaffer, J.E. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA100, 3077-3082.
42. Luiken, J.J.F.P., Arumugam, Y., Dyck, D.J., Bell, R.C., Pelsers, M.L., Turcotte, L.P., Tandon, N.N., Glatz, J.F.C. & Bonen, A. 2001. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem276, 40567-40573.
43. Manco, M., Mingrone, G., Greco, A.V., Capristo, E., Gniuli, D., De Gaetano, A. & Gasbarrini, G. 2000. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism49, 220-224.
44. Mashek, D.G., Li, L.O. & Coleman, R.A. 2007. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol2, 465-476.
45. Mayerson, A.B., Hundal, R.S., Dufour, S., Lebon, V., Befroy, D., Cline, G.W., Enocksson, S., Inzucchi, S.E., Shulman, G.I. & Petersen, K.F. 2002. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes51, 797-802.
46. Molero, J.C., Lee, S., Leizerman, I., Chajut, A., Cooper, A. & Walder, K. 2010. Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus. Biochim Biophys Acta1802, 235-239.
47. Muurling, M., Mensink, R.P., Pijl, H., Romijn, J.A., Havekes, L.M. & Voshol, P.J. 2003. Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice. Metabolism52, 1078-1083.
48. Nickerson, J.G., Alkhateeb, H., Benton, C.R., Lally, J., Nickerson, J., Han, X.X., Wilson, M.H., Jain, S.S., Snook, L.A., Glatz, J.F., Chabowski, A., Luiken, J.J. & Bonen, A. 2009. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 than FABPPM and FATP, and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem284, 16522-16530.
49. Riccardi, G., Giacco, R. & Rivellese, A.A. 2004. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr23, 447-456.
50. Roy, C., Paglialunga, S., Fisette, A., Schrauwen, P., Moonen-Kornips, E., St-Onge, J., Hesselink, M.K., Richard, D., Joanisse, D.R. & Cianflone, K. 2008. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet. Am J Physiol Endocrinol Metab294, E1051-E1059.
51. Schmitz-Peiffer, C. 2000. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal12, 583-594.
52. Shulman, G.I. 2000. Cellular mechanisms of insulin resistance. J Clin Invest106, 171-176.
53. Smith, A.C., Mullen, K.L., Junkin, K.A., Nickerson, J., Chabowski, A., Bonen, A. & Dyck, D.J. 2007. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab293, E172-E181.
54. Storlien, L.H., Higgins, J.A., Thomas, T.C., Brown, M.A., Wang, H.Q., Huang, X.F. & Else, P.L. 2000. Diet composition and insulin action in animal models. Br J Nutr83, S85-S90.
55. Vessby, B., Tengblad, S. & Lithell, H. 1994. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologica37, 1044-1050.
56. van der Vusse, G.J., Roemen, T.H. & Reneman, R.S. 1980. Assessment of fatty acids in dog left ventricular myocardium. Biochim Biophys Acta617, 347-349.
57. Wierzbicki, M., Chabowski, A., Zendzian-Piotrowska, M., Harasim, E. & Górski, J. 2009. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding. Adv Med Sci54, 59-65.
58. Ye, J.M., Dzamko, N., Cleasby, M.E., Hegarty, B.D., Furler, S.M., Cooney, G.J. & Kraegen, E.W. 2004. Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia47, 1306-1313.